Cui Cui
Stock Analyst at Jefferies
(4.44)
# 1,167
Out of 5,022 analysts
35
Total ratings
60.6%
Success rate
32.2%
Average return
Main Sectors:
Stocks Rated by Cui Cui
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HKG: 2269 WuXi Biologics (Cayman) Inc. | Reiterated: Buy | $45.00 → $60.00 | $54.55 | +9.99% | 2 | Aug 27, 2026 | |
| HKG: 1548 Genscript Biotech Corporation | Reiterated: Buy | $15.50 → $30.00 | $43.72 | -31.38% | 2 | Aug 20, 2026 | |
| HKG: 6618 JD Health International Inc. | Reiterated: Buy | $88.00 → $80.00 | $34.64 | +130.95% | 4 | Aug 17, 2026 | |
| HKG: 0241 Alibaba Health Information Technology Limited | Reiterated: Buy | $8.00 → $5.30 | $2.82 | +88.28% | 2 | May 19, 2026 | |
| HKG: 9966 Alphamab Oncology | Reiterated: Buy | $9.60 | $8.31 | +15.59% | 1 | Mar 27, 2026 | |
| HKG: 1833 Ping An Healthcare and Technology Company Limited | Reiterated: Hold | $12.40 | $6.16 | +101.30% | 1 | Mar 25, 2026 | |
| HKG: 9926 Akeso, Inc. | Reiterated: Buy | $226.00 | $106.80 | +111.61% | 3 | Oct 19, 2025 | |
| HKG: 9606 Duality Biotherapeutics, Inc. | Reiterated: Buy | $500.00 | $195.70 | +155.49% | 2 | Oct 8, 2025 | |
| HKG: 6990 Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | Reiterated: Buy | $300.00 → $520.00 | $472.20 | n/a | 3 | Aug 19, 2025 | |
| HKG: 1093 CSPC Pharmaceutical Group Limited | Reiterated: Sell | $5.00 | $9.93 | n/a | 1 | Jul 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $41.00 → $60.00 | $80.60 | n/a | 2 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $175.00 → $87.40 | $210.00 | n/a | 2 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40.00 | $96.25 | n/a | 1 | Jan 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4.00 | $2.15 | n/a | 1 | Jan 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10.80 | $7.95 | n/a | 1 | Jan 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26.00 | $14.73 | n/a | 1 | Nov 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $110.00 | $45.88 | n/a | 1 | Oct 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40.00 → $35.20 | $21.94 | n/a | 2 | Oct 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28.00 → $25.00 | $34.14 | n/a | 2 | Sep 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $10.00 | $15.85 | n/a | 1 | Apr 22, 2020 |
WuXi Biologics (Cayman) Inc.
Aug 27, 2026
Reiterated: Buy
Price Target: $45.00 → $60.00
Current: $54.55
Upside: +9.99%
Genscript Biotech Corporation
Aug 20, 2026
Reiterated: Buy
Price Target: $15.50 → $30.00
Current: $43.72
Upside: -31.38%
JD Health International Inc.
Aug 17, 2026
Reiterated: Buy
Price Target: $88.00 → $80.00
Current: $34.64
Upside: +130.95%
Alibaba Health Information Technology Limited
May 19, 2026
Reiterated: Buy
Price Target: $8.00 → $5.30
Current: $2.82
Upside: +88.28%
Alphamab Oncology
Mar 27, 2026
Reiterated: Buy
Price Target: $9.60
Current: $8.31
Upside: +15.59%
Ping An Healthcare and Technology Company Limited
Mar 25, 2026
Reiterated: Hold
Price Target: $12.40
Current: $6.16
Upside: +101.30%
Akeso, Inc.
Oct 19, 2025
Reiterated: Buy
Price Target: $226.00
Current: $106.80
Upside: +111.61%
Duality Biotherapeutics, Inc.
Oct 8, 2025
Reiterated: Buy
Price Target: $500.00
Current: $195.70
Upside: +155.49%
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Aug 19, 2025
Reiterated: Buy
Price Target: $300.00 → $520.00
Current: $472.20
Upside: n/a
CSPC Pharmaceutical Group Limited
Jul 30, 2025
Reiterated: Sell
Price Target: $5.00
Current: $9.93
Upside: n/a
Mar 27, 2025
Reiterated: Buy
Price Target: $41.00 → $60.00
Current: $80.60
Upside: n/a
Mar 21, 2025
Reiterated: Buy
Price Target: $175.00 → $87.40
Current: $210.00
Upside: n/a
Jan 22, 2025
Reiterated: Buy
Price Target: $40.00
Current: $96.25
Upside: n/a
Jan 22, 2025
Reiterated: Buy
Price Target: $4.00
Current: $2.15
Upside: n/a
Jan 22, 2025
Reiterated: Buy
Price Target: $10.80
Current: $7.95
Upside: n/a
Nov 3, 2023
Reiterated: Buy
Price Target: $26.00
Current: $14.73
Upside: n/a
Oct 31, 2023
Reiterated: Buy
Price Target: $110.00
Current: $45.88
Upside: n/a
Oct 27, 2023
Reiterated: Buy
Price Target: $40.00 → $35.20
Current: $21.94
Upside: n/a
Sep 4, 2023
Reiterated: Buy
Price Target: $28.00 → $25.00
Current: $34.14
Upside: n/a
Apr 22, 2020
Downgraded: Hold
Price Target: $10.00
Current: $15.85
Upside: n/a